# PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

> **NCT03664063** · PHASE2 · COMPLETED · sponsor: **Lihir Medical Centre** · enrollment: 42 (actual)

## Conditions studied

- Lymphatic Filariasis
- Yaws
- Trauma

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Albendazole
- **DRUG:** Ivermectin
- **DRUG:** Diethylcarbamazine

## Key facts

- **NCT ID:** NCT03664063
- **Lead sponsor:** Lihir Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664063, "PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03664063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*